SEARCH

SEARCH BY CITATION

REFERENCES

  • References to studies included in this review
  • Bada 1989 {published data only}
  • *Bada HS, Green RS, Pourcyrous M, et al.Indomethacin reduces the risks of severe intraventricular hemorrhage. J Pediatr 1989;115:631-7.
  • Bada HS, Green RS, Pourcyrous M, Leffler CW, Korones SB, Arheart K. Indomethacin reduces relative risks of severe intraventricular hemorrhage [Abstract]. Ped Res 1989;25:353A.
  • Pourcyrous M, Bada HS, Green RS, Korones SB. Safety of indomethacin use for newborn infants [Abstract]. Ped Res 1988;23:422A.
  • Bandstra 1988 {published data only}
  • *Bandstra ES, Montalvo BM, Goldberg RN, et al.Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics 1988;82:533-542.
  • Bandstra ES, Bauer CR, Duenas ML, Chao H, Montalvo BM, Bancalari E. Prophylactic indomethacin for prevention of intraventricular hemorrhage: neurodevelopmental follow-up [Abstract]. Ann Neurol 1987;22:427A.
  • Bandstra ES, Duenas ML, Rodriguez I, et al.Prophylactic indomethacin for the prevention of intraventricular hemorrhage (IVH): neurodevelopmental follow-up [Abstract]. Pediatr Res 1987;21:391.
  • Setzer ES, Morse BM, Goldberg RN, Smith M, Bancalari E. Prophylactic indomethacin and intraventricular hemorrhage in the premature [Abstract]. Ped Res 1984;18:345A.
  • Setzer ES, Smith M, Goulding PJ, Bandstra TE. Severity of platelet dysfunction induced by prophylactic indomethacin in the premature [Abstract]. Pediatr Res 1984;18:346A.
  • Setzer ES, Torres-Arraut E, Gomez-del-Rio M, Young ML, Pacheco I, Ferrer PL, et al.Cardiopulmonary effects of prophylactic indomethacin in the very low birth weight infant [Abstract]. Ped Res 1984;18:346A.
  • Couser 1996 {published data only}
  • *Couser RJ, Ferrara TB, Wright GB, Cabalka AK, Schilling CG, et al.Prophylactic indomethacin therapy in the first 24 hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room. J Pediatr 1996;128:631-637.
  • Couser RJ, Hoekstra RE, Ferrara B, Wright GB, Cabalka AK, Connet JE. Neurodevelopmental follow-up at 36 months' corrected age of preterm infants treated with prophylactic indomethacin. Arch Pediatr Adolesc Med 2000;154:598-602.
  • Domanico 1994 {published data only}
  • Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant-treated infants < 1250 grams. Ped Res 1994;35:331A.
  • Gutierrez 1987 {published data only}
  • Gutierrez NG, Lapasset M. Prophylactic indomethacin and the incidence of patent ductus arteriosus in preterm neonates. Proceedings of the 3rd Argentinian Congress of Perinatology, Buenos Aires. 1987; Vol. 62.
  • Hanigan 1988 {published data only}
  • Hanigan WC, Kennedy G, Roemisch F, et al.Administration of indomethacin for the prevention of periventricular haemorrhage in high-risk neonates. J Pediatr 1988;112:941-7.
  • Krueger 1987 {published data only}
  • Krueger E, Mellander M, Bratton D, Cotton R. Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin. J Pediatr 1987;111:749-54.
  • Mahony 1985 {published data only}
  • Mahony L, Caldwell RL, Girod DA, et al.Indomethacin therapy on the first day of life in infants with very low birth weight. J Pediatr 1985;106:801-5.
  • Ment 1985 {published data only}
  • Ment LR, Duncan CC, Ehrenkranz RA, et al.Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants. J Pediatr 1985;107:937-943.
  • Ment 1988 {published data only}
  • Ment LR, Duncan CC, Ehrenkranz RA, et al.Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates. J Pediatr 1988;112:948-55.
  • Ment 1994a {published data only}
  • Ment LR, Oh W, Ehrenkranz, Phillip AGS, et al.Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial. J Pediatr 1994;124:951-5.
  • Ment 1994b {published data only}
  • Ment L, Vohr B, Allan W, Westerveld M, Sparrow S, Schneider K, Katz K, Duncan C, Makuch R. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics 2000;105:485-491.
  • Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJW, Scott DT. Randomized low-dose indomethacin trial for the prevention of intraventricular hemorrhage in very low birth weight neonates [Abstract]. Ann Neurol 1987;22:406-407.
  • Ment LR, Oh W, Ehrenkranz, Phillip AGS, et al.Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93:543-550.
  • Ment LR, Vohr B, Oh W, Scott DT, Allen WC, Westerveld M, Duncan CC, Ehrenkranz RA, Katz KH, Schneider KC, Makuch RW. Neurodevelopmental outcome at 36 months corrected age of preterm infants in the multicenter indomethacin intraventricular hemorrhage prevention trial. Pediatrics 1996;98:714-718.
  • Morales-Suarez 1994 {published data only}
  • Morales-Suarez M, Sanchez-Gil T, Lemus-Varela L. Low dose indomethacin for prevention of intraventricular hemorrhage in the preterm infant with mechanical ventilation: Final report of a randomized study [Estudio comparavito de dosis baja de indometacina profilactica para hemorragia subependimaria/intraventricular en neonatos pretermino con ventilation mecanica]. Bol Med Hosp Infant Mex 1994;51:389-394.
  • Puckett 1985 {published data only}
  • Puckett CG, Cox MA, Haskins KS, Fisher DJ. Prophylactic indomethacin (I) for the prevention of patent ductus arteriosus (PDA) [Abstract]. Pediatr Res 1985;19:358.
  • Rennie 1986a {published data only}
  • Rennie JM, Doyle J, Cooke RWI. Early administration of indomethacin to preterm infants. Arch Dis Child 1986;61:233-238.
  • Supapannachart 1999 {published data only}
  • Supapannachart S, Khowsathit P, Patchakapati B. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams. J Med Assoc Thai 1999;82:S87-S91.
  • TIPP 2001 {published data only}
  • Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL and the TIPP investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants (PMID: 11430325). New Engl J Med 2001;344:1966-1972. [MEDLINE: 11430325]
  • Vincer 1985 {published data only}
  • *Vincer M, Allen A, Evans J, et al.Early intravenous indomethacin prolongs respiratory support in very low birth weight infants. Acta Paediatr Scand 1985;76:894-897.
  • Vincer M, Allen A. Does prophylactic indomethacin in VLBW (<1500 grams birth weight) infants cause cerebral palsy (CP)?. Pediatr Res 1998;43:232.
  • Yaseen 1997 {published data only}
  • Yaseen H, al Umran K, Ali H, Rustum M, Darwich M, al-Faraidy A. Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants. J Trop Pediatr 1997;43:42-46.
  • References to studies excluded from this review
  • Bada 1996 {published data only}
  • Bada HS, Yolton KA, Duncan C, Wong SP, Pourcyrous M, Korones SB. Indomethacin (INDO) prophylaxis and outcome at school age [abstract]. Ped Res 1996;39:373A.
  • Cotton 1980 {published data only}
  • Cotton RB, Hickey DE, Graham TP, Stahlman MT. Effects of early indomethacin (I) on ventilatory status of preterm infants with symptomatic patent ductus arteriosus (sPDA) [abstract]. Ped Res 1980;14:442A.
  • Cotton 1983 {published data only}
  • Cotton L, Hickey D, Stahlman MT. Management of premature infants with symptomatic patent ductus arteriosus Intensive. In: SternL editor(s). Care in the Newborn. IV. New York: Masson Publishing Co, 1983:225-231.
  • Gersony 1983 {published data only}
  • Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895-906.
  • Peckham GJ, Miettinen OS, Ellison RC, Kraybill EN, Gersony WM, Zeirler S, Nadas AS. Clinical course to 1 year if age in premature infants with patent ductus arteriosus: results of a multicenter randomized trial of indomethacin. J Pediatr 1984;104:285-291.
  • Hammerman 1986 {published data only}
  • Hammerman C, Strates E, Valaitis S. The silent ductus: its precursors and its aftermath. Pediatric Cardiology 1986;7:121-127.
  • Hammerman 1987 {published data only}
  • Hammerman C, Strates E, Komar K, Bui K. Failure of prophylactic indomethacin to improve the outcome of the very low birth weight infant. Dev Pharmacol Ther 1987;10:393-404.
  • Hammerman 1990 {published data only}
  • Hammerman C, Aramburo MJ. Prolonged indomethacin therapy for the prevention of recurrences of patent ductus arteriosus. J Pediatr 1990;117:771-776.
  • Hammerman 1995 {published data only}
  • Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI. Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. Pediatrics 1995;95:244-248.
  • Kaapa 1983 {published data only}
  • Kaapa P, Lanning P, Koivisto M. Early closure of patent ductus arteriosus with indomethacin in preterm infants with idiopathic respiratory distress syndrome. Acta Paediatr Scand 1983;72:179-184.
  • Krauss 1989 {published data only}
  • Krauss AN, Fatica N, Lewis BS, Cooper R, Thaler HT, Cirrincione C, O'Loughlin J, Levin A, Engle MA, Auld PAM. Pulmonary function in preterm infants following treatment with intravenous indomethacin. Am J Dis Child 1989;143:78-81.
  • Lai 1990 {published data only}
  • Lai TH, Soong WJ, Hwang B. Indomethacin for the prevention of symptomatic patent ductus arteriosus in very low birth weight infants. Acta Paediatrica Sinica 1990;31:17-23.
  • Mahony 1982 {published data only}
  • *Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very low birth weight infants. N Eng J Med 1982;306:506-510.
  • Mahony L, Heymann MA, Carnero V, Brett C, Clyman RI. When to treat the patent ductus arteriosus with indomethacin in very low birth weight infants. Adv Prostaglandin Thromboxane Leukot Res 1983;12:491-494.
  • Mardoum 1991 {published data only}
  • Mardoum R, Bejar R, McFeely E, Peterson B, Merritt TA. Controlled study of the effects of indomethacin (INDO) on the cerebral blood flow velocities in the newborn infant [Abstract]. Ped Res 1988;23:554.
  • * Mardoum R, Bejar R, Merritt A, Berry C. Controlled study of the effects of indomethacin on cerebral blood flow velocities in newborn infants. J Pediatr 1991;118:112-115.
  • Ment 1987 {published data only}
  • Ment LR, Duncan CC, Ehrenkranz RA, Kleinman CS, Taylor KJW, Scott DT. Randomized low-dose indomethacin trial for the prevention of intraventricular hemorrhage in very low birth weight neonates [Abstract]. Ann Neurol 1987;22:406-407.
  • Ment 1993 {published data only}
  • Ment LR, Oh W, Ehrenkrantz RA, Philip AGS, Schneider K, Katz KH, Taylor KJW, Duncan CC, Makuch. Risk period for intraventricular hemorrhage of the preterm neonate is independent of gestational age. Sem Perinatol 1993;17:338-341.
  • Merritt 1981 {published data only}
  • Merritt TA, Harris JP, Roghmann K, Wood B, Campanella V, Alexzon C, Manning J, Shapiro DL. Early closure of patent ductus arteriosus in very low birth weight infants: a controlled trial. J Pediatr 1981;99:281-286.
  • Monset-Couchard 1983 {published data only}
  • Monset-Couchard M, Dias-Mancano D, Murat I, Relier JP. Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants [French]. Pediatrie 1983;38:365-377.
  • Mullett 1982 {published data only}
  • *Mullett MD, Croghan TW, Myerberg DZ, Krall JM, Neal WA. Indomethacin closure of patent ductus arteriosus in prematures. Clin Pediatr 1982;21:217-220.
  • Mullett MD, Crogan TW, Myerberg DZ, Neal WA. Administration of oral indomethacin (I) to prematures with patent ductus arteriosus (PDA): a randomized double blind study [Abstract]. Ped Res 1980;14:606.
  • Nestrud 1980 {published data only}
  • Nestrud RM, Hill DE, Arrington RW, Beard AG, Dungan WT, Norton JB, Radinger RI. Indomethacin treatment in patent ductus arteriosus. A double blind study utilizing indomethacin plasma levels. Dev Pharmacol Ther 1980;1:125-136.
  • Neu 1980 {published data only}
  • Neu J, Ariagno RL, Johnson JD, Pitlick PT, Cohen JS, Beets CL. A double blind study of the effects of oral indomethacin (IN) in preterm infants with patent ductus arteriosus (PDA) who failed medical management [Abstract]. Ped Res 1980;14:607.
  • Rennie 1991 {published data only}
  • Rennie JM, Cooke RWI. Prolonged low dose indomethacin for persistent ductus arteriosus of prematurity. Arch Dis Child 1991;66:55-58.
  • Rhodes 1988 {published data only}
  • Rhodes PG, Ferguson MG, Reddy NS, Joransen JA, Gibson J. Effects of prolonged versus acute indomethacin therapy in very low birth weight infants with patent ductus arteriosus. Eur J Paediatr 1988;147:481-484.
  • Rudd 1983 {published data only}
  • Rudd P, Montanez P, Hallidie-Smith K, Silverman M. Indomethacin treatment for patent ductus arteriosus in very low birthweight infants: double blind trial. Arch Dis Child 1983;58:267-270.
  • Valaes 1980 {published data only}
  • Valaes T, Moylan FMB, Cohn H, Chung K, Nagpaul K, Chrenoff HL, Kreidberg MB. Incidence and significance of PDA in preterm infants (PTI) and controlled blind trial of indomethacin (IND) [Abstract]. Ped Res 1980;14:452.
  • van Overmeire 1995 {published data only}
  • Van Overmeire B, Brus F, Van Acker KJ, et al.Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Ped Res 1995;38:886-891.
  • Vogtmann 1988 {published data only}
  • Vogtmann C, Grubbe G, Ruckhaberle KE, Bottcher H, Ockert C. Effects of early therapy with indomethacin on the manifestation of a persistent ductus arteriosus in extremely underweight premature infants [German]. [Monatsschrift Kinderheilkunde 1988;136:636-639.
  • Wagner 1984 {published data only}
  • Wagner HR, Ellison C, Zierler S, Lang P, Purohit DM, Behrendt D, Waldhausen JA. Surgical closure of patent ductus arteriosus in 268 preterm infants. J Thorac Cardiovasc Surg 1984;87:870-875.
  • Weesner 1987 {published data only}
  • Weesner KM, Dillard RG, Boyle RJ, Block SM. Prophylactic treatment of asymptomatic ductus arteriosus in premature infants with respiratory distress syndrome. South Med J 1987;80:706-708.
  • Wurtzel 1990 {published data only}
  • Wurtzel D. Prenatal administration of indomethacin as a tocolytic agent: effect on neonatal renal function. Obstet Gynecol 1990;76:689-692.
  • Yanagi 1981 {published data only}
  • Yanagi RM, Wilson A, Newfeld EA, Aziz KU, Hubt CE. Indomethacin treatment for symptomatic patent ductus arteriosus: a double blind control study. Pediatrics 1981;67:647-652.
  • Yeh 1981 {published data only}
  • *Yeh TF, Luken JA, Thalji A, Raval D, Carr I, Pildes RS. Intravenous indomethacin therapy in premature infants with persistent ductus arteriosus - a double blind controlled study. J Pediatr 1981;98:137-145.
  • Betkerur MV, Yeh TF, Miller K, Glasser RJ, Pildes RS. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus. Pediatrics 1981;68:99-102.
  • Yeh TF, Goldbarg HR, Henek T, Thalji A, Pildes RS. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one year follow-up. Am J Dis Child 1982;136:803-807.
  • Yeh TF, Raval D, Pyati S, Pildes RS. Retinopathy of prematurity (ROP) and indomethacin therapy in premature infants with patent ductus arteriosus (PDA). Prostaglandins 1983;25:385-391.
  • Yeh TF, Thalji A, Luken L, Lilien L, Carr I, Pildes RS. Improved lung compliance following indomethacin therapy in premature infants with patent ductus arteriosus. Chest 1981;80:698-700.
  • Yeh TF, Wilks A, Singh J, Betkerur M, Lilien L, Pildes RS. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus. J Pediatr 1982;101:433-437.
  • Zamboni 1993 {published data only}
  • Zamboni G, Piemonte G, Boner A, et al.Influence of dietry taurine on vitamin D absorption. Acta Paediatrica 1993;82:811-815.
  • References to studies awaiting assessment
  • Morales {published data only}
  • Morales-Suarez M, Lemus-Varella L, Udaeta-Mora E, Cardiel-Marmolejo L, Rodriguez-Balderrama I, Liz-Cedilla RE. Indomethacin in the prevention of subependymal-intraventricular hemorrhage in preterm newborns with conventional mechanical ventilation. Bol Med Hosp Infant Mex 1992;49:217-24.
  • Additional references
  • Brown 1979
  • Brown ER. Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979;95:865.
  • Cifuentes 1979
  • Cifuentes RF, Olley PM, Balfe JW, et al.Indomethacin and renal function in premature infants with persistent patent ductus arteriosus. J Pediatr 1979;95:583-7.
  • Coombs 1990
  • Coombs RC, Morgan MEI, Durbin GM, et al.Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990;65:1067-71.
  • Edwards 1990
  • Edwards AD, Wyatt JS, Richardson C, et al.Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990;335:1491-5.
  • Fowlie 1996
  • Fowlie PW. Prophylactic indomethacin: systematic review and meta-analysis. Arch Dis Child 1996;74:F81-F87.
  • Friedman 1978
  • Friedman Z, Whitman V, Maisels MJ, et al.Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants. J Clin Pharmacol 1978;18:272-279.
  • Herson 1988
  • Herson VC, Krause PJ, Eisenfeld LI, et al.Indomethacin associated sepsis in the very low birth weight infant. Am J Dis Child 1988;142:555-58.
  • Heymann 1976
  • Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Eng J Med 1976;295:530-3.
  • Kitterman 1972
  • Kitterman JA, Edmunds LH Jn, Gregory GA, Heymann MA, et al.Patent ductus arteriosus in premature infants: incidence and relation to pulmonary disease and management. N Eng J Med 1972;287:473.
  • Lipman 1982
  • Lipman B, Server GA, Brazy JE. Abnormal cerebral haemodynamics in preterm infants with patent ductus arteriosus. Pediatrics 1982;69:778-781.
  • Ment 1983
  • Ment LA, Stewart WB, Duncan CC, et al.Beagle puppy model of intraventricular haemorrhage: effect of indomethacin on cerebral blood flow. J Neurosurgery 1983;58:857.
  • Ment 1992
  • Ment LA, Stewart WB, Ardito TA, et al.Indomethacin promotes germinal matrix maturation in the newborn beagle puppy. Stroke 1992;23:1132-37.
  • Nehgme 1992
  • In: SinclairJC, BrackenMB editor(s). Effective care of the newborn infant. Oxford: Oxford University Press, 285-289, 403-405, 568-571, 606-607, 624-625.
  • References to other published versions of this review
  • Fowlie 1997
  • Fowlie PW. Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants. Cochrane Database of Systematic Reviews 1997, Issue 3. [DOI: 10.1002/14651858.CD000174]